Contact
searchSearch
HMP Global

Advertisement

ADVERTISEMENT

Volume 7 - Issue 11 - November 2010

Insights

Interview
Latest Study Results from VEITHsymposium on Ultrasound-Accelerated Catheter-Directed Thrombolysis
11/22/2010

Dr. Peter H. Lin 

Dr. Peter H. Lin 
At the recently concluded 37th Annual VEITHsymposium™ in New York, Peter H. Lin, MD, Professor of Surgery and Chief, Division of Vascular Surgery and Endovascular Therapy at Baylor College of Medicine (Houston, Texas), reported his findings...
At the recently concluded 37th Annual VEITHsymposium™ in New York, Peter H. Lin, MD, Professor of Surgery and Chief, Division of Vascular Surgery and Endovascular Therapy at Baylor College of Medicine (Houston, Texas), reported his findings...
At the recently concluded 37th...
11/22/2010
Vascular Disease Management

Feature

Case Report
Rectus Sheath Hematoma as a Complication of Ablation of Atrial Fibrillation
11/03/2010
Along with review of the pathophysiology and anatomy of this entity we report a case of a rectus sheath hematoma complicating an atrial fibrillation ablation procedure and propose methods for treatment and prevention.
Along with review of the pathophysiology and anatomy of this entity we report a case of a rectus sheath hematoma complicating an atrial fibrillation ablation procedure and propose methods for treatment and prevention.
Along with review of the...
11/03/2010
Vascular Disease Management
Review
Percutaneous Pulmonary Embolectomy: Indications, Techniques and Outcomes
11/03/2010
Venous thromboembolic disease remains the third most common cardiovascular disease and one of the leading causes of sudden death in the United States. The true incidence of pulmonary embolism (PE) is unknown, but based on historic...
Venous thromboembolic disease remains the third most common cardiovascular disease and one of the leading causes of sudden death in the United States. The true incidence of pulmonary embolism (PE) is unknown, but based on historic...
Venous thromboembolic disease...
11/03/2010
Vascular Disease Management
Original Research
A Conservative Approach to Acute Upper Limb Ischemia
11/03/2010

E. Jane H. Turner, PhD, MRCS£, Alexander Loh, FRCS*, Adam Howard, FRCS§

E. Jane H. Turner, PhD, MRCS£, Alexan...
Few studies report the use of conservative management in the treatment of acute upper limb ischemia (AULI). A retrospective series is presented from a hospital where a conservative approach is used primarily.
Few studies report the use of conservative management in the treatment of acute upper limb ischemia (AULI). A retrospective series is presented from a hospital where a conservative approach is used primarily.
Few studies report the use of...
11/03/2010
Vascular Disease Management
Review
Critical Limb Ischemia: Surgical Perspectives and Options
11/03/2010

Samir K. Shah, MD*, Khanjan H. Baxi, MD§, Daniel G. Clair, MD*

Samir K. Shah, MD*, Khanjan H. Baxi, ...
Critical limb ischemia (CLI) is a common vascular pathology with profound medical and socioeconomic implications. Eight to ten million Americans are presently thought to suffer from peripheral arterial disease, with approximately 500–1,000...
Critical limb ischemia (CLI) is a common vascular pathology with profound medical and socioeconomic implications. Eight to ten million Americans are presently thought to suffer from peripheral arterial disease, with approximately 500–1,000...
Critical limb ischemia (CLI) is...
11/03/2010
Vascular Disease Management

Advertisement

Advertisement

Stay in the Know

Vascular Disease Management Newsletter

Advertisement

Advertisement

News

News
Double Win With Bridging Stents: FEVAR Certifications for BeGraft and BeFlared
11/20/2024
Hechingen, November 20th, 2024. With two certificates granted by TÜV, Bentley achieved another break-through in extending indications for its stents in complex aortic interventions. Thanks to one certificate, the Bentley BeGraft stent now is...
Hechingen, November 20th, 2024. With two certificates granted by TÜV, Bentley achieved another break-through in extending indications for its stents in complex aortic interventions. Thanks to one certificate, the Bentley BeGraft stent now is...
Hechingen, November 20th, 2024....
11/20/2024
Vascular Disease Management
First Aid guidelines
AHA/American Red Cross: Updated First Aid Guidelines Enhance Care for Opioid Overdose, Bleeding, Other Emergencies
11/14/2024
These are the first major comprehensive updates to the first aid guidelines since 2010 and address shifts in how the public manages common and critical first aid emergencies.
These are the first major comprehensive updates to the first aid guidelines since 2010 and address shifts in how the public manages common and critical first aid emergencies.
These are the first major...
11/14/2024
Cath Lab Digest
Late-Breaking Trials
Final Round of Late-Breaking Clinical Trial Results Announced at VIVA24
11/06/2024
The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announces the results for the final round of Late-Breaking Clinical Trials presented at...
The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announces the results for the final round of Late-Breaking Clinical Trials presented at...
The VIVA Foundation, a...
11/06/2024
Vascular Disease Management
Late-Breaking Trials
Third Round of Late-Breaking Clinical Trial Results Announced at VIVA24
11/05/2024
The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announces the results for the third of four rounds of Late-Breaking Clinical Trials...
The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announces the results for the third of four rounds of Late-Breaking Clinical Trials...
The VIVA Foundation, a...
11/05/2024
Vascular Disease Management
Late-Breaking Trials
Second Round of Late-Breaking Clinical Trial Results Announced at VIVA24
11/04/2024
The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announces the results for the second of four rounds of Late-Breaking Clinical Trials...
The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announces the results for the second of four rounds of Late-Breaking Clinical Trials...
The VIVA Foundation, a...
11/04/2024
Vascular Disease Management
Late-Breaking Trials
First Round of Late-Breaking Clinical Trial Results Announced at VIVA24
11/04/2024
The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announces the results for the first of four rounds of Late-Breaking Clinical Trials...
The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announces the results for the first of four rounds of Late-Breaking Clinical Trials...
The VIVA Foundation, a...
11/04/2024
Vascular Disease Management
Image-Guided Therapy
Philips Enrolls First Patient in U.S. Clinical Trial for Innovative Integrated Single-Device to Treat Peripheral Artery Disease
11/04/2024
With a unique world-first ability to perform laser atherectomy and laser-based intravascular lithotripsy using a single device, Philips takes a major step forward in the treatment of peripheral artery disease (PAD) Cardiovascular...
With a unique world-first ability to perform laser atherectomy and laser-based intravascular lithotripsy using a single device, Philips takes a major step forward in the treatment of peripheral artery disease (PAD) Cardiovascular...
With a unique world-first...
11/04/2024
Vascular Disease Management
Pulmonary Embolism
Akura Medical Secures FDA Approval for US Pivotal Trial in Pulmonary Embolism
11/04/2024
QUADRA-PE study will evaluate the safety and effectiveness of the Katana™ Thrombectomy System LOS GATOS, Calif., Nov. 4, 2024 /PRNewswire/ -- Akura Medical, a Shifamed portfolio company focused on reshaping the...
QUADRA-PE study will evaluate the safety and effectiveness of the Katana™ Thrombectomy System LOS GATOS, Calif., Nov. 4, 2024 /PRNewswire/ -- Akura Medical, a Shifamed portfolio company focused on reshaping the...
QUADRA-PE study will evaluate...
11/04/2024
Vascular Disease Management
Peripheral Arterial Disease
FDA Grants R3 Vascular IDE Approval for ELITE-BTK Pivotal Trial of its MAGNITUDE® Drug Eluting Next Generation Bioresorbable Scaffold for Below-the-Knee Peripheral Arterial Disease
11/04/2024
MOUNTAIN VIEW, Calif. – November 4, 2024 – R3 Vascular Inc., a medical device company dedicated to developing and providing novel, best-in-class bioresorbable scaffolds for treating peripheral arterial disease (PAD), is pleased to announce...
MOUNTAIN VIEW, Calif. – November 4, 2024 – R3 Vascular Inc., a medical device company dedicated to developing and providing novel, best-in-class bioresorbable scaffolds for treating peripheral arterial disease (PAD), is pleased to announce...
MOUNTAIN VIEW, Calif. – November...
11/04/2024
Vascular Disease Management
Patient Awareness
Baby Boomers Beware: More Americans Than Ever Before Now at Higher Risk for Common Blood Vessel Diseases
10/31/2024
New survey reveals nearly one in three Americans at highest risk for blood vessel diseases and life-threatening complications report low awareness Society for Vascular Surgery launches the Highway to Health campaign to help people maintain...
New survey reveals nearly one in three Americans at highest risk for blood vessel diseases and life-threatening complications report low awareness Society for Vascular Surgery launches the Highway to Health campaign to help people maintain...
New survey reveals nearly one in...
10/31/2024
Vascular Disease Management

Advertisement

Advertisement

November 2010 Volume 7 Issue 11

View Issue Archive
Editorial Correspondence

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use

Advertisement

Advertisement